Supplemental material
Open access
5,205
Views
15
CrossRef citations to date
0
Altmetric
Hematology
Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
Rachel H. Bhaka Analysis Group, Inc, Boston, MA, USACorrespondence[email protected]
https://orcid.org/0000-0002-4027-647X
, https://orcid.org/0000-0002-4027-647X
Nikita Mody-Patelb Apellis Pharmaceuticals, Inc, Waltham, MA, USA
, Scott B. Baverb Apellis Pharmaceuticals, Inc, Waltham, MA, USA
, Colin Kunzweilera Analysis Group, Inc, Boston, MA, USA
, Christopher W. Yeea Analysis Group, Inc, Boston, MA, USA
, Sanjana Sundaresana Analysis Group, Inc, Boston, MA, USA
, Natalia Swartza Analysis Group, Inc, Boston, MA, USA
, Mei Sheng Duha Analysis Group, Inc, Boston, MA, USA
, Sangeeta Krishnanb Apellis Pharmaceuticals, Inc, Waltham, MA, USA
& Sujata P. Sardab Apellis Pharmaceuticals, Inc, Waltham, MA, USA
show all
Pages 1913-1923
|
Received 26 Apr 2021, Accepted 14 Aug 2021, Published online: 03 Sep 2021
Related Research Data
Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
Source:
Taylor & Francis
Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
Source:
Taylor & Francis
Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.